Tonix Pharmaceuticals Announces FDA Acceptance of the New Drug Application (Nda) for Tnx-102 Sl for Fibromyalgia
Tonix Pharmaceuticals宣布FDA接受针对Tnx-102 SL用于纤维肌痛症的新药申请(NDA)
Tonix Pharmaceuticals Announces FDA Acceptance of the New Drug Application (Nda) for Tnx-102 Sl for Fibromyalgia
Tonix Pharmaceuticals宣布FDA接受针对Tnx-102 SL用于纤维肌痛症的新药申请(NDA)
使用浏览器的分享功能,分享给你的好友吧